Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
Tiziana Life Sciences announced PET imaging results from the third Multiple System Atrophy patient treated with its lead candidate, intranasal foralumab, showing significant reductions in neuroinflammation in key brain regions. These consistent findings across patients strengthen confidence in foralumab's potential to modulate neuroinflammation and…